Discordant genetic changes in ovarian and endometrial endometrioid carcinomas: A potential pitfall in molecular diagnosis

Keyphrases

• Molecular Diagnostics 100%
• Genetic Changes 100%
• Microsatellite Markers 100%
• Endometrioid Endometrial Carcinoma 100%
• Ovarian Endometrioid Carcinoma 100%
• Tumor 50%
• Metastasis 50%
• Primary Tumor 50%
• Ovarian Cancer 50%
• Ovarian Tumor 50%
• Uterus 25%
• Paraffin-embedded Tissue 25%
• High Stage 25%
• Genetic Modification 25%
• Microsatellite Instability-high (MSI-H) 25%
• Genomic Instability 25%
• Clonality 25%
• Diagnostic Challenge 25%
• Stage III-IV 25%
• Metastatic Tumor 25%
• Loss of Heterozygosity 25%
• Endometrioid Carcinoma 25%
• Endometrial Carcinoma 25%
• BAT26 25%
• Microsatellite Loci 25%
• Multiplex PCR (mPCR) 25%
• Uterine Corpus 25%
• Uterine Tumors 25%
• Uterine Involvement 25%
• FIGO Stage I 25%

Medicine and Dentistry

• Gene Mutation 100%
• Molecular Diagnosis 100%
• Endometrioid Carcinoma 100%
• Microsatellite Marker 100%
• Metastatic Carcinoma 75%
• Primary Tumor 50%
• Ovarian Cancer 50%
• Ovarian Tumor 50%
• Neoplasm 25%
• Microsatellite Instability 25%
• Clonal Variation 25%
• Heterozygosity 25%
• Endometrium Carcinoma 25%
• Tumor 25%
• Multiplex Polymerase Chain Reaction 25%
• Uterus Tumor 25%
• Genomic Instability 25%

Biochemistry, Genetics and Molecular Biology

• Gene Mutation 100%
• Microsatellite Marker 100%
• Microsatellite Instability 25%
• Clonality 25%
• Clonal Variation 25%
• Loss of Heterozygosity 25%
• Microsatellite 25%
• Multiplex Polymerase Chain Reaction 25%
• Discordance (Genetics) 25%
• Genomic Instability 25%